POSA411 Real World Outcomes of First Line Pembrolizumab Monotherapy for Advanced PD-L1 Positive Non-Small Cell Lung Cancer
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.1237
https://www.valueinhealthjournal.com/article/S1098-3015(21)03032-1/fulltext
Title :
POSA411 Real World Outcomes of First Line Pembrolizumab Monotherapy for Advanced PD-L1 Positive Non-Small Cell Lung Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)03032-1&doi=10.1016/j.jval.2021.11.1237
First page :
Section Title :
Open access? :
No
Section Order :
10776